About the measures
The data include records for girls and boys who had completed the three dose course of the HPV vaccination in accordance with the Chief Medical Officer guidelines. Under these guidelines, valid HPV vaccination is considered to have occurred where there is a total interval of 111 or more days between the first and third doses, or, for those aged 15 and under, a gap between the first and third doses of 74 or more days.3
HPV immunisation status is assessed at age 15 to allow for completion of the immunisation schedule by all eligible recipients. Reporting by this age group accommodates the varying ages of vaccination around Australia (usually in the first year of high school, around ages 12–13).
Immunisation rates were mapped to the area in which people lived rather than the area where services were provided, using postcode information provided to the HPV Register at the time of their final vaccination.
The immunisation rates presented here are not comparable with those produced by the HPV Register due to methodological differences. The HPV Register reports current coverage for each cohort at the date of data extraction. Therefore, the number fully immunised may vary in reports prepared by the HPV Register. A further difference is the HPV Register’s use of ABS ERP at age 15, which differs to the method used here.
|Girls who were fully immunised against HPV||Boys who were fully immunised against HPV|
|PHN area||SA4||PHN area||SA4|
|Reported with caution (#)||2||12||2||11|
3. Department of Health and Ageing 2009. Chief Medical Officer Guidance on revaccination where HPV vaccine doses have been given at less than recommended minimum intervals January 2009. Canberra: Department of Health and Ageing. Viewed 20 February 2017, http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/cmo-full-advice-hpv-cnt/$File/CMO-full-advice-hpv.pdf.